225 related articles for article (PubMed ID: 12204716)
1. Prostaglandin-induced hair growth.
Johnstone MA; Albert DM
Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S185-202. PubMed ID: 12204716
[TBL] [Abstract][Full Text] [Related]
2. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost.
Johnstone MA
Am J Ophthalmol; 1997 Oct; 124(4):544-7. PubMed ID: 9323945
[TBL] [Abstract][Full Text] [Related]
3. Lash ptosis caused by latanoprost.
Casson RJ; Selva D
Am J Ophthalmol; 2005 May; 139(5):932-3. PubMed ID: 15860312
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of iridial pigmentation and eyelash changes due to ophthalmic treatment with latanoprost.
Chiba T; Kashiwagi K; Ishijima K; Furuichi M; Kogure S; Abe K; Chiba N; Tsukahara S
Jpn J Ophthalmol; 2004; 48(2):141-7. PubMed ID: 15060793
[TBL] [Abstract][Full Text] [Related]
5. Eyelash hypertrichosis in a patient treated with topical latanoprost.
Strober BE; Potash S; Grossman ME
Cutis; 2001 Feb; 67(2):109-10. PubMed ID: 11236218
[TBL] [Abstract][Full Text] [Related]
6. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia.
Blume-Peytavi U; Lönnfors S; Hillmann K; Garcia Bartels N
J Am Acad Dermatol; 2012 May; 66(5):794-800. PubMed ID: 21875758
[TBL] [Abstract][Full Text] [Related]
7. [Adverse reaction after use of latanoprost in Japanese glaucoma patients].
Inoue K; Wakakura M; Inoue J; Matsuo H; Hara T; Tomita G
Nippon Ganka Gakkai Zasshi; 2006 Aug; 110(8):581-7. PubMed ID: 16972649
[TBL] [Abstract][Full Text] [Related]
8. Influence of prostaglandin F2alpha and its analogues on hair regrowth and follicular melanogenesis in a murine model.
Sasaki S; Hozumi Y; Kondo S
Exp Dermatol; 2005 May; 14(5):323-8. PubMed ID: 15854125
[TBL] [Abstract][Full Text] [Related]
9. Eyelid hypertrichosis associated with latanoprost is reversible.
O'Toole L; Cahill M; O'Brien C
Eur J Ophthalmol; 2001; 11(4):377-9. PubMed ID: 11820311
[TBL] [Abstract][Full Text] [Related]
10. Eyelash hypertrichosis induced by topical latanoprost: 6-month follow-up study.
Stecchi G; Saccucci S; Molinari S; De Gregorio F
Acta Ophthalmol Scand Suppl; 2002; 236():56-7. PubMed ID: 12390146
[No Abstract] [Full Text] [Related]
11. Eyelash formation secondary to latanoprost treatment in a patient with alopecia.
Mansberger SL; Cioffi GA
Arch Ophthalmol; 2000 May; 118(5):718-9. PubMed ID: 10815168
[No Abstract] [Full Text] [Related]
12. [Side-effects and risk profile of latanoprost 0.005% (Xalatan)].
Schlote T
Ophthalmologe; 2002 Sep; 99(9):724-9. PubMed ID: 12219263
[TBL] [Abstract][Full Text] [Related]
13. Five-year, multicenter safety study of fixed-combination latanoprost/timolol (Xalacom) for open-angle glaucoma and ocular hypertension.
Alm A; Grunden JW; Kwok KK
J Glaucoma; 2011; 20(4):215-22. PubMed ID: 20520568
[TBL] [Abstract][Full Text] [Related]
14. Hypertrichosis of vellus hairs of the malar region after unilateral treatment with bimatoprost.
Hart J; Shafranov G
Am J Ophthalmol; 2004 Apr; 137(4):756-7. PubMed ID: 15059720
[TBL] [Abstract][Full Text] [Related]
15. Hypertrichosis of the malar areas and poliosis of the eyelashes caused by latanoprost.
Özyurt S; Çetinkaya GS
Actas Dermosifiliogr; 2015; 106(1):74-5. PubMed ID: 25065768
[No Abstract] [Full Text] [Related]
16. Promising alternative clinical uses of prostaglandin F2α analogs: beyond the eyelashes.
Choi YM; Diehl J; Levins PC
J Am Acad Dermatol; 2015 Apr; 72(4):712-6. PubMed ID: 25601618
[TBL] [Abstract][Full Text] [Related]
17. The comparison of eyelash lengthening effect of latanoprost therapy in adults and children.
Elgin U; Batman A; Berker N; Ilhan B
Eur J Ophthalmol; 2006; 16(2):247-50. PubMed ID: 16703542
[TBL] [Abstract][Full Text] [Related]
18. Expression of the L-fucose moiety on infrainfundibular follicular keratinocytes of terminal follicles, its decreased expression on vellus and indeterminate follicles of androgenetic alopecia, and re-expression in drug-induced hair regrowth.
Heng MC; Levine S; Fine H; Allen SG; Heng MK
J Invest Dermatol; 1992 Jan; 98(1):73-8. PubMed ID: 1370232
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory autocrine factors produced by the mesenchyme-derived hair follicle dermal papilla may be a key to male pattern baldness.
Hamada K; Randall VA
Br J Dermatol; 2006 Apr; 154(4):609-18. PubMed ID: 16536801
[TBL] [Abstract][Full Text] [Related]
20. Inner canthus hypertrichosis: a side effect of prostaglandin analogue treatment for glaucoma.
Monselise A; Shapiro J; Lui H
J Cutan Med Surg; 2011; 15(5):298-9. PubMed ID: 21962192
[No Abstract] [Full Text] [Related]
[Next] [New Search]
